Recent evidence investigates the association between ERCC1 mRNA expression levels and clinical findings after treatment with a combination of gemcitabine and cisplatin for patients with advanced-stage nonsmall-cell lung cancer [43]. Here, ERCC1 is linked to lung cancer.